GE Healthcare, Insightec Get FDA Ok for Exablate Neuro W/ Signa

July 10, 2019, 4:37 PM UTC

GE Healthcare and Insightec announced FDA approval and CE mark for Exablate Neuro compatible with the Signa Premier MRI system.

  • Exablate Neuro is a focused ultrasound platform for treating deep in the brain with no surgical incisions
  • Exablate Neuro has FDA approval for the treatment of medication-refractory essential tremor and tremor-dominant Parkinson’s disease and CE mark for the treatment of Essential Tremor, Tremor Dominant Parkinson’s Disease-Unilateral and neuropathic pain

Link to Statement: INSIGHTEC Receives FDA Approval and CE Mark for Exablate Neuro With GE SIGNA Premier MR System

©2019 Bloomberg L.P. All rights reserved. Used with permission

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.